Listed

Sonos Inc: Form 10-Q for the period ended Mar 28, 2026

Filed with the SEC on May 5, 2026 and accepted by EDGAR at May 4, 2026, 17:57 ET.

Share

Management's discussion and analysis

As filed, 41,845 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q and with our audited consolidated financial statements included in our Annual Report.

We operate on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. Our fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding future operations and performance, are forward-looking statements. In some cases, forward-looking statements may be identified by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "could," "would," "expect," "objective," "plan," "potential," "seek," "grow," "target," "if," and similar expressions intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations, objectives, restructuring efforts, cost initiatives, timing of certain tax impacts and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in the section titled "Risk Factors" set forth in Part I, Item 1A of the Annual Report and in our other SEC filings. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results may differ materially and adversely from those anticipated or implied in the forward-looking statements. You should read this Quarterly Report on Form 10-Q with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Overview

Sonos is a leading audio company dedicated to elevating life through sound. Since pioneering multi-room wireless audio in 2005, Sonos has built a system that unites every dimension of sound - music, movies, stories and conversations - into one connected platform. The portfolio includes home theater speakers, components, plug-in and portable speakers, and headphones that compound in value with every room and device its customers add. Known for exceptional sound, thoughtful design, ease of use and seamless access to the world’s audio content, Sonos is trusted by more than 17 million households in 60+ countries around the world.

We are building on the strong foundation established during our transformational year in fiscal 2025. With Tom Conrad now in place as our Chief Executive Officer we are well-positioned to continue building upon the improvements we have made to our software products and operational efficiency. Under Mr. Conrad's direction, we have restored our software with reliability now exceeding historical levels, reorganized our operations to improve our efficiency and effectiveness and recommitted to delivering the kind of premium experience our customers expect. We recommitted to new product introductions, including the announcement of Amp Multi in January 2026, followed by Sonos Play™ and Sonos Era 100™ SL in March 2026. With every new product, software feature and integration, the Sonos platform becomes more powerful, provides greater value to our customers, and further strengthens as the differentiated system for connected home audio. Additionally, we are refining our go-to-market strategy around a full-funnel brand architecture designed to align our long-term brand narrative with a consistent messaging system.

Our cost transformation initiative, which began in fiscal 2024, has delivered meaningful results. The organizational restructuring we completed—including workforce reductions of 6% in August 2024 and 12% in February 2025—has created a more streamlined, agile organization. We remain focused on transformation efforts to continually improve both our operational efficiency and effectiveness. Additionally, during the third quarter of fiscal 2025, we began the process of exiting a partnership with one of our contract manufacturers to consolidate and improve supply chain efficiency. We completed the operational exit with minimal disruption to our business during the second quarter of fiscal 2026. We continue to maintain diversified contract manufacturing partnerships.

Macroeconomic Conditions and Other Factors Affecting our Business

Our business has been, and may continue to be, adversely impacted by the potential expansion of tariffs on goods imported into the U.S., as well as any retaliatory tariffs or policies enacted in other countries or any "trade wars." In addition, we have been and may continue to be affected by the increases in demand for memory chips and other components caused by the build out of new AI technologies and data centers. We also face global macroeconomic challenges such as inflation, ongoing geopolitical conflicts, uncertainty in the financial markets, volatility in exchange rates, and low or negative growth in certain regions.

Global economic and political conditions and uncertainties, as well as global trade tensions and memory supply constraints, have caused and may continue to cause volatility in demand for our products as well as cost of materials and logistics, and as a result may impact our results of operations. We are continuing to evaluate and implement mitigating actions, including evaluating our pricing strategy across the portfolio and new product pipeline, taking measures to manage our expenses and contain costs, leveraging our supply chain flexibility, inventory management and engineering optimization.

For additional information, see Part II, Item 1A "Risk Factors."

Seasonality

Historically, we have typically experienced the highest levels of revenue in the first fiscal quarter of the year coinciding with the holiday shopping season and our promotional activities.

Key Metrics

We use the following key metrics, including measures presented in our condensed consolidated financial statements, to evaluate our business, measure our performance, identify trends affecting our business and assist us in making operational and strategic decisions. Our key metrics are total revenue, products sold, Adjusted EBITDA, and Adjusted EBITDA margin. The most directly comparable financial measure calculated under U.S. GAAP for Adjusted EBITDA is net income (loss). The most directly comparable financial measure calculated under U.S. GAAP for Adjusted EBITDA margin is net income (loss) margin.

(In thousands, except percentages)

Three Months Ended March 28, 2026 March 29, 2025 Six Months Ended March 28, 2026 March 29, 2025
Total revenue $281,526 $259,756 $827,189 $810,613
Products sold 788 768 2,581 2,618
Net income (loss) $(28,886) $(70,144) 64,912 (19,907)
Net income (loss) margin(1) (10.3)% (27.0)% 7.8% (2.5)%
Adjusted EBITDA(2) $1,717 $(826) 133,856 90,347
Adjusted EBITDA margin(2) 0.6% (0.3)% 16.2% 11.1%

(1) Net income (loss) margin is calculated by dividing net income (loss) by revenue.

(2) For additional information regarding Adjusted EBITDA and Adjusted EBITDA margin (which are non-GAAP financial measures), including reconciliations of net income to Adjusted EBITDA, see the section titled "Non-GAAP Financial Measures" below.

Products Sold

Products sold represents the number of products that are sold during a period, net of returns, and includes units sold from the Sonos speakers and Sonos system products categories, as well as architectural speakers sold through our partnerships from our Partner products and other revenue category. Growth rates between products sold and revenue are not perfectly correlated because our revenue is affected by other variables, such as the mix of products sold during the period, promotional discount activity, the price at which we sell our products, the introduction of new products that may have higher or lower than average selling prices, the impact of foreign exchange rate fluctuations, as well as the impact of recognition of previously deferred revenue.

Non-GAAP Financial Measures

To supplement our condensed consolidated financial statements presented in accordance with U.S. GAAP, we use Adjusted EBITDA, Adjusted EBITDA margin, and constant currency which are non-GAAP financial measures. We use these non-GAAP financial measures to evaluate our operating performance and trends and make planning decisions. We believe that these non-GAAP financial measures help identify underlying trends in our business that could otherwise be masked by the effect of the expenses and other items that we exclude from these non-GAAP financial measures. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects, and allowing for greater transparency with respect to a key financial metric used by our management in its financial and operational decision-making.

We define Adjusted EBITDA as net income (loss) adjusted to exclude the impact of depreciation and amortization, stock-based compensation expense, interest income, interest expense, other income (expense), income taxes, legal and transaction related costs, restructuring and other costs, and other items that we do not consider representative of underlying operating performance. We define Adjusted EBITDA margin as Adjusted EBITDA divided by revenue.

We present percentage sales growth in constant currency to show performance unaffected by fluctuations in currency exchange rates. We calculate constant currency growth percentages by translating our current period financial results using the prior period average currency exchange rates and comparing these amounts to our prior period reported results.

These non-GAAP financial measures are not based on standardized methodology prescribed by U.S. GAAP and are not necessarily comparable to similarly titled measures presented by other companies. Furthermore, other companies may not publish these or similar metrics. These metrics may also have certain limitations as they do not include the impact of certain expenses that are reflected in our condensed consolidated statements of operations and comprehensive income, including stock-based compensation, which has been and will continue to be, a significant recurring expense for our business and an important part of our compensation strategy. Because of these limitations, these non-GAAP financial measures should be considered along with other operating and financial performance measures presented in accordance with U.S. GAAP.

The following table presents a reconciliation of net income (loss) to Adjusted EBITDA:

(In thousands, except percentages)

Three Months Ended March 28, 2026 March 29, 2025 Six Months Ended March 28, 2026 March 29, 2025
Net income (loss) $(28,886) $(70,144) $64,912 $(19,907)
Add (deduct):
Depreciation and amortization 11,841 15,167 25,862 32,778
Stock-based compensation expense 14,864 20,102 30,056 45,436
Interest income (1,911) (1,973) (3,260) (3,834)
Interest expense 104 109 220 219
Other (income) expense, net 1,361 (193) 941 5,836
Provision for (benefit from) income taxes (2,243) 10,977 6,027 4,555
Legal and transaction related costs(1) 3,523 1,429 6,034 1,624
Restructuring and other charges(2)(3) 3,064 23,700 3,064 23,640
Adjusted EBITDA $1,717 $(826) $133,856 $90,347
Revenue $281,526 $259,756 $827,189 $810,613
Net income (loss) margin (10.3)% (27.0)% 7.8% (2.5)%
Adjusted EBITDA margin 0.6% (0.3)% 16.2% 11.1%

(1) Legal and transaction-related costs consist of expenses related to our intellectual property ("IP") litigation against Alphabet and Google, which we do not consider representative of our underlying operating performance.

(2) Restructuring and other charges for the three and six months ended March 28, 2026, include costs associated with non-recurring organizational changes driven by new leadership, charges related to the partial abandonment of office space in support of operational efficiencies, and costs associated with exiting a partnership with one of our contract manufacturers to consolidate and improve supply chain efficiency.

(3) Restructuring and other charges for the three and six months ended March 29, 2025 primarily reflect costs associated with our cost transformation initiative including the 2025 restructuring plan and rationalization of our product roadmap, as well as non-recurring CEO transition costs related to modifications to equity awards.

Results of Operations

Comparison of the three and six months ended March 28, 2026 and March 29, 2025

Revenue by Product

Comparison of the three and six months ended March 28, 2026 and March 29, 2025

(In thousands)

Three Months Ended March 28, 2026 March 29, 2025 Change $% Six Months Ended March 28, 2026 March 29, 2025 Change $%
Sonos speakers $210,018 $194,519 $15,499 8.0% $669,258 $661,661 $7,597 1.1%
% of total revenue 74.6% 74.9% 80.9% 81.6%
Sonos system products 52,411 50,540 1,871 3.7 117,469 110,814 6,655 6.0
% of total revenue 18.6% 19.5% 14.2% 13.7%
Partner products and other revenue 19,097 14,697 4,400 29.9 40,462 38,138 2,324 6.1
% of total revenue 6.8% 5.7% 4.9% 4.7%
Total revenue $281,526 $259,756 $21,770 8.4% $827,189 $810,613 $16,576 2.0%
Volume data (products sold in thousands) Units% Units%
Total products sold 788 768 20 2.6% 2,581 2,618 (37) (1.4)%

We generate substantially all of our revenue from the sale of Sonos speakers and Sonos system products. We also generate a portion of revenue from Partner products and other revenue sources, such as architectural speakers from our Sonance partnership, accessories such as speaker stands and wall mounts, professional services, licensing, and advertising revenue.

Total revenue increased $21.8 million, or 8.4 %, for the three months ended March 28, 2026 compared to the three months ended March 29, 2025, due to favorability from foreign exchange rates and continued strength in Era 100.

Sonos speakers revenue represented 74.6% of total revenue for the three months ended March 28, 2026 and increased 8.0 % compared to the three months ended March 29, 2025, primarily driven by Era 100 and Beam. Sonos system products represented 18.6% of total revenue for the three months ended March 28, 2026 and increased 3.7% compared to the three months ended March 29, 2025. Partner products and other revenue represented 6.8% of total revenue for the three months ended March 28, 2026 and increased 29.9% compared to the three months ended March 29, 2025.

The volume of products sold increased 2.6 % for the three months ended March 28, 2026 compared to the three months ended March 29, 2025. Revenue growth exceeded volume growth primarily due to favorable foreign exchange rates, which benefited revenue but did not affect volume, and the impact of pricing actions.

Total revenue increased $16.6 million, or 2.0%, for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, primarily due to favorability from foreign exchange rates and continued strength in Era 100, partially offset by softer demand due to market conditions.

Sonos speakers revenue represented 80.9% of total revenue for the six months ended March 28, 2026 and increased 1.1% compared to the six months ended March 29, 2025, primarily driven by Arc Ultra and Era 100, partially offset by declines in Arc and Sub. Sonos system products represented 14.2% of total revenue for the six months ended March 28, 2026 and increased 6.0% compared to the six months ended March 29, 2025, due to higher sales to our installed solutions channel. Partner products and other revenue represented 4.9% of total revenue for the six months ended March 28, 2026 and increased 6.1% compared to the six months ended March 29, 2025.

The volume of products sold decreased 1.4% for the six months ended March 28, 2026 compared to the six months ended March 29, 2025. Revenue grew while volume declined, primarily due to favorable foreign exchange rates, which benefited revenue but did not impact volume, and the impact of pricing actions.

Revenue by Region

The following table presents the change in revenue for the three and six months ended March 28, 2026 compared with the three and six months ended March 29, 2025:

Three Months Ended March 28, 2026 Change (%) Constant Currency Change (%)(1) Six Months Ended March 28, 2026 Change (%) Constant Currency Change (%)(1)
Americas 2.2% 1.3% 1.6% 1.2%
EMEA 20.9% 9.1% 2.3% (5.6)%
APAC 25.3% 18.1% 5.3% 3.4%
Total revenue 8.4% 4.3% 2.0% (0.9)%

(1) Constant currency is a financial measure that is not calculated in accordance with U.S. GAAP. For additional information, see the section titled "Non-GAAP Financial Measures" above.

Cost of Revenue and Gross Profit

Comparison of the three and six months ended March 28, 2026 and March 29, 2025

(In thousands, except percentages)

Three Months Ended March 28, 2026 March 29, 2025 Change $% Six Months Ended March 28, 2026 March 29, 2025 Change $%
Cost of revenue $156,877 $146,147 $10,730 7.3% $449,080 $455,597 $(6,517) (1.4)%
Gross profit $124,649 $113,609 $11,040 9.7% $378,109 $355,016 $23,093 6.5%
Gross margin 44.3% 43.7% 45.7% 43.8%

Cost of Revenue

Cost of revenue consists of product costs, including costs of our contract manufacturers for production, components, shipping and handling, tariffs, duty costs, warranty replacement costs, packaging, fulfillment costs, manufacturing and tooling equipment depreciation, warehousing costs, hosting costs, and excess and obsolete inventory write-downs. It also includes licensing costs, such as royalties to third parties, and amortization attributable to acquired developed technology. In addition, we attribute certain costs to cost of revenue related to management and facilities, personnel-related expenses, and supply chain logistic costs. Personnel-related expenses consist of salaries, bonuses, benefits, and stock-based compensation expenses.

Cost of revenue increased $10.7 million, or 7.3 %, for the three months ended March 28, 2026 compared to the three months ended March 29, 2025, primarily due to tariff expenses and higher memory costs, partially offset by a decrease in product and material costs.

Cost of revenue decreased $6.5 million, or 1.4%, for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, primarily due to a decrease in product and material costs and fewer inventory-related write-downs, partially offset by increased tariff expenses and higher memory costs.

Gross Margin

Our gross margin fluctuates from period to period based on a number of factors, including the mix of products we sell, the mix of channels through which we sell our products, fluctuations of our product and material cost savings, fluctuations in our product and material and logistics markets, product pricing strategies and promotional activity, the foreign currency in which our products are sold, and tariffs and duty costs implemented by governmental authorities.

Gross margin increased 60 basis points for the three months ended March 28, 2026 compared to the three months ended March 29, 2025, primarily due to foreign exchange rate favorability, the net impact of pricing changes, and a decrease in product and material costs, partially offset by tariff expenses and higher memory costs.

Gross margin increased 190 basis points for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, primarily due to a decrease in product and material costs, foreign exchange rate favorability, a decrease in inventory-related write-downs, and the net impact of pricing changes, partially offset by tariff expenses, higher memory costs, and unfavorable product mix.

Operating Expenses

Comparison of the three and six months ended March 28, 2026 and March 29, 2025

(Dollars in thousands)

Three Months Ended March 28, 2026 March 29, 2025 Change $% Six Months Ended March 28, 2026 March 29, 2025 Change $%
Research and development $64,134 $77,423 $(13,289) (17.2)% $123,896 $158,261 $(34,365) (21.7)%
Less restructuring and other charges(1)(2) 857 12,766 (11,909) (93.3) 857 12,706 (11,849) (93.3)
Research and development, net of restructuring and other charges $63,277 $64,657 $(1,380) (2.1)% $123,039 $145,555 $(22,516) (15.5)%
Sales and marketing $62,376 $64,210 $(1,834) (2.9)% $127,650 $150,854 $(23,204) (15.4)%
Less restructuring and other charges(1)(2) 1,453 2,792 (1,339) (48.0) 1,453 2,792 (1,339) (48.0)%
Sales and marketing, net of restructuring and other charges $60,923 $61,418 $(495) (0.8)% $126,197 $148,062 $(21,865) (14.8)%
General and administrative $29,714 $33,200 $(3,486) (10.5)% $57,723 $59,032 $(1,309) (2.2)%
Less restructuring and other charges(1)(2) 90 4,207 (4,117) (97.9) 90 4,207 (4,117) (97.9)%
General and administrative, net of restructuring and other charges $29,624 $28,993 $631 2.2% $57,633 $54,825 $2,808 5.1%
Operating expenses $156,224 $174,833 $(18,609) (10.6)% $309,269 $368,147 $(58,878) (16.0)%
Less restructuring and other charges(1)(2) 2,400 19,765 (17,365) (87.9) 2,400 19,705 (17,305) (87.8)
Operating expenses, net of restructuring and other charges $153,824 $155,068 $(1,244) (0.8)% $306,869 $348,442 $(41,573) (11.9)%

(1) Restructuring and other charges for the three and six months ended March 28, 2026, include costs associated with non-recurring organizational changes driven by new leadership, charges related to the partial abandonment of office space in support of operational efficiencies, and costs associated with exiting a partnership with one of our contract manufacturers to consolidate and improve supply chain efficiency.

(2) Restructuring and other charges for the three and six months ended March 29, 2025 primarily reflect costs associated with our cost transformation initiative including the 2025 restructuring plan and rationalization of our product roadmap, as well as non-recurring CEO transition costs related to modifications to equity awards.

Research and Development

Research and development expenses consist primarily of personnel-related expenses, third-party resource expenses, tooling, test equipment, prototype materials, and related overhead costs. To date, software development costs have been expensed as incurred because the period between achieving technological feasibility and the release of the software has been short and development costs qualifying for capitalization have been insignificant.

Research and development expenses, excluding restructuring and other charges, decreased $1.4 million, or 2.1 %, for the three months ended March 28, 2026, compared to the three months ended March 29, 2025. This decrease was primarily driven by lower stock-based compensation related to timing of grants as well as favorable comparison to one time retention grants for key personnel in the prior year.

Research and development expenses, excluding restructuring and other charges, decreased $22.5 million, or 15.5 %, for the six months ended March 28, 2026, compared to the six months ended March 29, 2025. This decrease was primarily driven by lower headcount and our reorganization efforts.

Sales and Marketing

Sales and marketing expenses consist primarily of advertising and marketing activity for our products and personnel-related expenses, maintenance and repair expenses for our product displays, as well as depreciation, customer experience expenses, revenue related sales fees from our direct-to-consumer and installer solution sales channels, and related overhead costs.

Sales and marketing expenses, excluding restructuring and other charges, decreased $0.5 million, or 0.8 %, for the three months ended March 28, 2026, compared to the three months ended March 29, 2025. This decrease was primarily driven by ongoing savings efforts associated with cost transformation initiatives, offset by costs associated with announced product launches.

Sales and marketing expenses, excluding restructuring and other charges, decreased $21.9 million, or 14.8 %, for the six months ended March 28, 2026, compared to the six months ended March 29, 2025. This decrease was primarily driven by ongoing savings as a result of our cost transformation journey, lower marketing costs due to the timing of our launch of Arc Ultra in October 2024, and lower personnel-related costs due to lower headcount.

General and Administrative

General and administrative expenses consist of administrative personnel-related expenses for our information technology, finance, legal, human resources, and similar personnel, as well as the costs of professional services, information technology, litigation, patents, related overhead, and other administrative expenses.

General and administrative expenses, excluding restructuring and other charges, increased $0.6 million, or 2.2 %, for the three months ended March 28, 2026, compared to the three months ended March 29, 2025. This increase was primarily driven by legal fees mainly related to our IP litigation, offset by lower stock-based compensation mainly due to timing of grants.

General and administrative expenses, excluding restructuring and other charges, increased $2.8 million, or 5.1%, for the six months ended March 28, 2026, compared to the six months ended March 29, 2025. This increase was primarily driven by an increase in legal fees mainly related to our IP litigation, partially offset by lower personnel-related costs due to lower headcount.

Interest Income, Interest Expense, and Other Income (Expense), Net

Comparison of the three and six months ended March 28, 2026 and March 29, 2025

(In thousands, except percentages)

Three Months Ended March 28, 2026 March 29, 2025 Change $% Six Months Ended March 28, 2026 March 29, 2025 Change $%
Interest income $1,911 $1,973 $(62) (3.1)% $3,260 $3,834 $(574) (15.0)%
Interest expense (104) (109) 5 (4.6) (220) (219) (1) 0.5
Other income (expense), net (1,361) 193 (1,554) * (941) (5,836) 4,895 (83.9)
Total other income (expense), net $446 $2,057 $(1,611) (78.3)% $2,099 $(2,221) $4,320 *
* Not meaningful

Interest income consists primarily of interest income earned on our cash, cash equivalents, and marketable securities balances. Interest expense consists primarily of interest expense associated with our debt financing arrangements and amortization of debt issuance costs. Other income (expense), net consists primarily of our foreign currency exchange gains and losses relating to transactions and remeasurement of asset and liability balances denominated in currencies other than the U.S. dollar. We expect our foreign currency gains and losses to continue to fluctuate in the future due to changes in foreign currency exchange rates.

Interest income and interest expense for the three months ended March 28, 2026 compared to the three months ended March 29, 2025, remained relatively consistent. Other income (expense), net for the three months ended March 28, 2026 compared to the three months ended March 29, 2025, increased from other income of $0.2 million for the three months ended March 29, 2025 to other expense of $1.4 million for the three months ended March 28, 2026 due to foreign currency exchange fluctuations.

Interest income for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, decreased due to higher international cash balances with lower yields. Interest expense for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, remained relatively consistent. Other income (expense), net for the six months ended March 28, 2026 compared to the six months ended March 29, 2025, decreased due to foreign currency exchange fluctuations.

Provision for (Benefit from) Income Taxes

Comparison of the three and six months ended March 28, 2026 and March 29, 2025

(In thousands, except percentages)

Three Months Ended March 28, 2026 March 29, 2025 Change $% Six Months Ended March 28, 2026 March 29, 2025 Change $%
Provision for (benefit from) income taxes $(2,243) $10,977 $(13,220) (120.4)% $6,027 $4,555 $1,472 32.3%

We are subject to income taxes in the United States and foreign jurisdictions in which we operate. Foreign jurisdictions have statutory tax rates different from those in the United States. Accordingly, our effective tax rate will vary depending on jurisdictional mix of earnings, and changes in tax laws. In addition, certain U.S. tax regulations subject the earnings of our non-U.S. subsidiaries to current taxation in the United States. Our effective tax rate will be impacted by our ability to claim deductions and foreign tax credits to offset the taxation of foreign earnings in the United States. On July 4, 2025, H.R. 1, commonly referred to as the One Big Beautiful Bill Act (“OBBBA”), was enacted. The legislation includes provisions such as accelerated cost recovery of qualified property, immediate expensing of U.S.-based research and development costs, and changes to the U.S. international taxation regime.

We recognized an income tax benefit of $2.2 million and an income tax provision of $11.0 million for the three months ended March 28, 2026 and March 29, 2025, respectively. For the three months ended March 28, 2026, the repeal of the requirement to capitalize research and experimental expenditures under the OBBBA resulted in a reduction in the Company’s U.S. current tax expense with no impact to deferred tax expense as a result of the full valuation allowance maintained against the Company’s net U.S. deferred tax assets. The tax provision for the three months ended March 29, 2025 primarily resulted from the application of a negative annual effective tax rate to year-to-date U.S. pre-tax loss for the quarter, which was driven in part by the capitalization of research and experimental expenditures under Section 174 and the valuation allowance maintained against U.S. deferred tax assets. We recognized tax provisions of $6.0 million and $4.6 million for the six months ended March 28, 2026 and March 29, 2025, respectively. This increase was driven by a change in the prescribed U.S. GAAP method to calculate the interim income tax benefit for the period ending March 28, 2026 versus the method used to calculate the income tax provision for the period ending March 29, 2025.

Liquidity and Capital Resources

Our operations are financed primarily through cash flows from operating activities. As of March 28, 2026, our principal sources of liquidity consisted of cash flows from operating activities, cash and cash equivalents of $200.2 million, including $111.2 million held by our foreign subsidiaries, marketable securities of $48.9 million, proceeds from the exercise of stock options, and borrowing capacity under the credit facility under our Revolving Credit Agreement. In accordance with our policy, the undistributed earnings of our non-U.S. subsidiaries remain indefinitely reinvested outside of the United States as of March 28, 2026, as they are intended to fund needs outside of the United States. In the event funds from foreign operations are repatriated to the United States, we may incur income or withholding taxes associated with such distributions. In addition, certain of our non-U.S. subsidiaries have the ability to repatriate funds to the United States in a tax-free manner.

As of March 28, 2026, our open purchase orders to contract manufacturers for finished goods were approximately $92 million, the majority of which are expected to be paid over the next six months. As of March 28, 2026, our expected commitments to suppliers for components were in the range of $198 million to $222 million, the majority of which is expected to be paid and/or utilized by our contract manufacturers in building finished goods within the next two years. The expected commitments are subject to change as a result of fluctuations in the demand forecast, as well as ongoing negotiations with contract manufacturers and suppliers. These commitments are related to components that can be specific to Sonos products and comprised 1) indirect obligations to third-party manufacturers and suppliers, 2) the inventory owned by contract manufacturers procured to manufacture Sonos products, and 3) purchase commitments made by contract manufacturers to their upstream suppliers.

We believe our existing cash and cash equivalent balances, cash flows from operations and committed credit lines will be sufficient to meet our long-term working capital and capital expenditure needs for at least the next 12 months. We hold our cash with a diverse group of major financial institutions and have processes and safeguards in place to manage our cash balances and mitigate the risk of loss. In October 2021, we entered into the Revolving Credit Agreement, which was amended in October 2025 to provide for aggregate commitments of up to $80.0 million with a maturity date in October 2030. Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our rate of revenue growth, the timing and extent of spending on research and development efforts and other business initiatives, our planned sales and marketing activities, the timing of new product introductions, our potential merger and acquisition activity, market acceptance of our products, and overall economic conditions. To the extent that current and anticipated sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing. The sale of additional equity would result in increased dilution to our stockholders. If we were to incur additional debt financing, it would result in increased debt service obligations and the instruments governing such debt could require additional operating and financing covenants that would restrict our operations.

Debt Obligations

On October 13, 2021, we entered into the Revolving Credit Agreement which was amended in October 2025 with JPMorgan Chase Bank, N.A., KeyBank National Association and Goldman Sachs Bank USA. Amendment No. 2 to the Revolving Credit Agreement provides for (i) a five-year senior secured revolving credit facility in the amount of up to $80.0 million and (ii) an uncommitted incremental facility subject to certain conditions. Proceeds are to be used for working capital and general corporate purposes. The facility may be drawn as an Alternative Base Rate Loan (at 1.00% plus an applicable margin) or Term Benchmark Loan (SOFR plus an applicable margin). We must also pay (i) an unused commitment fee ranging from 0.200% to 0.275% per annum of the average daily unused portion of the aggregate revolving credit commitment under the agreement and (ii) a per annum fee equal to the applicable margin over SOFR multiplied by the aggregate face amount of outstanding letters of credit. As of March 28, 2026, we did not have any outstanding borrowings and had $2.4 million in undrawn letters of credit that reduce the availability under the Revolving Credit Agreement.

Our obligations under the Revolving Credit Agreement are secured by substantially all of our assets. The Revolving Credit Agreement contains customary representations and warranties, customary affirmative and negative covenants, a financial covenant that is tested quarterly and requires us to maintain a certain consolidated leverage ratio, and customary events of default. As of March 28, 2026, we were in compliance with all financial covenants under the Revolving Credit Agreement.

Cash Flows

The following table summarizes our cash flows for the periods indicated:

(In thousands)

Net cash provided by (used in): Six Months Ended March 28, 2026 March 29, 2025
Operating activities $97,933 $96,507
Investing activities (6,813) (17,162)
Financing activities (66,692) (74,194)
Effect of exchange rate changes 1,060 (1,725)
Net increase in cash and cash equivalents $25,488 $3,426

Cash flows from operating activities

Net cash provided by operating activities of $97.9 million for the six months ended March 28, 2026, consisted of net income of $64.9 million, non-cash adjustments of $62.8 million, and an unfavorable impact of net changes in operating assets and liabilities of $29.8 million. Non-cash adjustments primarily consisted of stock-based compensation expense and depreciation and amortization. The net decrease in cash from the change in operating assets and liabilities was primarily due to a decrease in accounts payable and accrued expenses of $33.3 million driven by payments for inventory purchases, and an increase in accounts receivable of $31.7 million driven by the timing of new product launches. The net decrease in cash from the change in operating assets and liabilities was partially offset by an increase in deferred revenue of $17.0 million driven by product general availability deferrals, and a decrease in inventories of $9.8 million due to seasonality.

Cash flows from investing activities

Cash used in investing activities of $6.8 million for the six months ended March 28, 2026, primarily consisted of the purchases of marketable securities of $25.2 million and purchases of property and equipment of $10.7 million mainly related to manufacturing-related tooling and test equipment to support the launch of new products, partially offset by cash provided by maturities of marketable securities of $29.1 million.

Cash flows from financing activities

Cash used in financing activities of $66.7 million for the six months ended March 28, 2026, primarily consisted of payments for repurchases of common stock of $65.1 million, and payments for repurchases of common stock related to shares withheld for tax in connection with vesting of stock awards of $15.9 million, partially offset by proceeds from the exercise of stock options of $15.1 million.

Commitments and Contingencies

See Note 7. Commitments and Contingencies in the notes to condensed consolidated financial statements.

Critical Accounting Policies and Estimates

Our unaudited condensed consolidated financial statements are prepared in accordance with U.S. GAAP. The preparation of these unaudited condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates.

Other than items discussed in Note 2 of our condensed consolidated financial statements, there have been no material changes to our critical accounting policies as compared to the critical accounting policies and significant judgments and estimates disclosed in our Annual Report on Form 10-K.

Market risk

As filed, 2,417 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to financial market risks, including changes in currency exchange rates and interest rates. For quantitative and qualitative disclosures about market risk, refer to Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk, in our Annual Report on Form 10-K. Our exposure to market risk has not changed materially, except as follows:

Foreign Currency Risk

Our inventory purchases are primarily denominated in U.S. dollars. Our international sales are primarily denominated in foreign currencies and any movement in the exchange rate between the U.S. dollar and the currencies in which we conduct sales in foreign countries could have an impact on our revenue, principally for sales denominated in the euro and the British pound. A portion of our operating expenses are incurred outside the United States and are denominated in foreign currencies, which are also subject to foreign currency exchange rate fluctuations. In certain countries where we may invoice customers in the local currency our revenues benefit from a weaker dollar and are adversely affected by a stronger dollar. The opposite impact occurs in countries where we record expenses in local currencies. In those cases, our costs and expenses benefit from a stronger dollar and are adversely affected by a weaker dollar.

We have not entered into any material foreign exchange contracts or derivatives to hedge any foreign currency exposures. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. Our continued international expansion increases our exposure to exchange rate fluctuations and, as a result, such fluctuations could have a significant impact on our future results of operations.

For the three months ended March 28, 2026 and March 29, 2025, we recognized a loss from foreign currency exchange of $1.4 million and gain of $0.2 million, respectively. For the six months ended March 28, 2026 and March 29, 2025, we recognized losses from foreign currency exchange of $0.9 million and $5.8 million, respectively. Based on transactions denominated in currencies other than the U.S. dollar as of March 28, 2026, a hypothetical adverse change of 10% would have resulted in an adverse impact on income (loss) before provision for (benefit from) income taxes of approximately $3.1 million and $12.3 million for the three and six months ended March 28, 2026.

Controls and procedures

As filed, 978 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required under Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended ("Exchange Act") as of March 28, 2026. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control

There were no changes in our internal control over financial reporting in management's evaluation pursuant to Rule 13a-15(f) during the quarter ended March 28, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 4,084 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our operations and financial results are subject to various risks and uncertainties, including the factors discussed in Part I, Item 1A, Risk Factors in our Annual Report on Form 10-K for the year ended September 27, 2025, which could adversely affect our business, reputation, financial condition and operating results, and affect the trading price of our common stock. Except as set forth below, there have been no material changes to the risk factors disclosed in our Annual Report.

We depend on a limited number of third-party components suppliers and logistics providers, and many of our components have long lead times, and our business and operating results could be adversely affected by shortages, disruptions and related challenges.

We are dependent on a limited number of suppliers for various key components used in our products, and we may from time to time have sole source suppliers. The cost, quality and availability of these components are essential to the successful production and sale of our products. We are subject to the risk of industry-wide shortages, price fluctuations and long lead times in the supply of these components and other materials. In particular, we have been and expect to continue to be adversely impacted by an increase in the cost of certain memory components the supply of which is currently constrained. If the supply of these components is delayed or constrained, or if one or more of our main suppliers were to go out of business, alternative sources or suppliers may not be available on acceptable terms or at all. In the event that any of our suppliers were to discontinue production of our key product components, developing alternate sources of supply for these components would be time consuming, difficult and costly. In the event we are unable to obtain components in sufficient quantities on a timely basis and on commercially reasonable terms, our ability to sell our products in order to meet market demand would be affected and could materially and adversely affect our brand, image, business prospects and operating results.

In addition, the longer lead time for many of our components presents challenges in our efforts to manage component inventory, as we procure such components based on our then current forecast of demand for our products. In the past, we have had to increase our purchase commitments and investments during industry-wide shortages. In the event that actual demand for our products differs from our forecast, we may end up with excess component inventory, negatively impacting our working capital.

We also use a small number of logistics providers for substantially all our product delivery to both distributors and retailers. If one of these providers were to experience financial difficulties or disruptions in its business, or be subject to closures or other disruptions, our own operations could be adversely affected. Because substantially all of our products are distributed from and into a small number of locations and by a small number of companies, we are susceptible to both isolated and system-wide interruptions caused by events out of our control. Any disruption to the operations of our distribution facilities could delay product delivery, harm our reputation among our customers and adversely affect our operating results and financial condition.

We have limited control over the third-party suppliers and logistics providers on which our business depends. If any of these parties fails to perform its obligations to us, we may be unable to deliver our products to customers in a timely manner. Further, we do not have long-term contracts with all of these parties, and there can be no assurance that we will be able to renew our contracts with them on favorable terms or at all. We may be unable to replace an existing supplier or logistics provider or supplement a provider in the event we experience significantly increased demand. Accordingly, a loss or interruption in the service of any key party could adversely impact our revenue, gross margin and operating results.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2026-03-28. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-12-28 to 2026-03-28$281.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2025-09-28 to 2026-03-28$827.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2025-12-28 to 2026-03-28$156.9mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2025-09-28 to 2026-03-28$449.1mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2025-12-28 to 2026-03-28$124.6mus-gaap:GrossProfit
Gross profit6 months2025-09-28 to 2026-03-28$378.1mus-gaap:GrossProfit
Research and development3 months2025-12-28 to 2026-03-28$64.1mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2025-09-28 to 2026-03-28$123.9mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2025-12-28 to 2026-03-28−$31.6mus-gaap:OperatingIncomeLoss
Operating income6 months2025-09-28 to 2026-03-28$68.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2025-12-28 to 2026-03-28$104.0kus-gaap:InterestExpenseNonoperating
Interest expense6 months2025-09-28 to 2026-03-28$220.0kus-gaap:InterestExpenseNonoperating
Income tax3 months2025-12-28 to 2026-03-28−$2.2mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2025-09-28 to 2026-03-28$6.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-12-28 to 2026-03-28−$28.9mus-gaap:NetIncomeLoss
Net income6 months2025-09-28 to 2026-03-28$64.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2025-12-28 to 2026-03-28−$0.24us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2025-09-28 to 2026-03-28$0.52us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-12-28 to 2026-03-28−$0.24us-gaap:EarningsPerShareBasic
Basic EPS6 months2025-09-28 to 2026-03-28$0.54us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-12-28 to 2026-03-28120,209,712 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2025-09-28 to 2026-03-28123,651,309 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2025-09-28 to 2026-03-28$97.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2025-09-28 to 2026-03-28$10.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2025-09-28 to 2026-03-28$65.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2026-03-28$200.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2026-03-28$540.1mus-gaap:AssetsCurrent
Total assetsAt period end2026-03-28$839.5mus-gaap:Assets
Current liabilitiesAt period end2026-03-28$341.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2026-03-28$455.1mus-gaap:Liabilities
Shareholders' equityAt period end2026-03-28$384.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001314727-26-000061. Last ingested by Listed: Nov 11, 2026, 01:22 ET. Listed shows no prices and gives no investment advice.